Alvarez-Cermeño JC - Search Results

1

Metabolomic signatures associated with disease severity in multiple sclerosis.

Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A. Villoslada P, et al. Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28180139 Free PMC article.

2

Intrathecal synthesis of soluble class I antigens in multiple sclerosis.

Alvarez-Cermeño JC, Villar LM, Nocito M, Bootello A, González-Porqué P. Alvarez-Cermeño JC, et al. J Neuroimmunol. 1992 Jan;36(1):77-9. doi: 10.1016/0165-5728(92)90032-g. J Neuroimmunol. 1992. PMID: 1735771

3

Soluble class I antigens in serum and CSF of patients with varicella-zoster virus meningitis.

Alvarez-Cermeño J, Echevarría JM, Villar LM, Lázaro I, Bootello A, González-Porque P. Alvarez-Cermeño J, et al. J Neurol Neurosurg Psychiatry. 1989 Oct;52(10):1194-6. doi: 10.1136/jnnp.52.10.1194. J Neurol Neurosurg Psychiatry. 1989. PMID: 2552020 Free PMC article.

4

Soluble class I antigen secretion by peripheral blood lymphocytes in multiple sclerosis.

Alvarez-Cermeño JC, Brieva JA, Villar LM, Roldán E, Bootello A, González-Porqué P. Alvarez-Cermeño JC, et al. Eur Neurol. 1993;33(3):229-31. doi: 10.1159/000116942. Eur Neurol. 1993. PMID: 8467843

5

Thioesterase and protein deacylase activities of porcine pancreatic phospholipase A2.

Nocito M, Roy G, Villar LM, Palacios C, Serrano A, Alvarez-Cermeño JC, González-Porqué P. Nocito M, et al. Biochim Biophys Acta. 1996 Jan 5;1299(1):17-22. doi: 10.1016/0005-2760(95)00176-x. Biochim Biophys Acta. 1996. PMID: 8555248

6

The expression of integrins on activated T-cells in multiple sclerosis. Effect of intravenous methylprednisolone treatment.

Luján S, Masjuan J, Roldán E, Villar LM, González-Porqué P, Alvarez-Cermeño JC. Luján S, et al. Mult Scler. 1998 Jun;4(3):239-42. doi: 10.1177/135245859800400328. Mult Scler. 1998. PMID: 9762681

7

Interferon beta-1b treatment in patients with relapsing--remitting multiple sclerosis under a standardized protocol in Spain.

Arbizu T, Alvarez-Cermeño JC, Decap G, Fernández O, Uría DF, García Merino A, Izquierdo G, Montalbán X. Arbizu T, et al. Acta Neurol Scand. 2000 Oct;102(4):209-17. doi: 10.1034/j.1600-0404.2000.102004209.x. Acta Neurol Scand. 2000. PMID: 11071104

8

Intrathecal IgM synthesis in neurologic diseases: relationship with disability in MS.

Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC. Villar LM, et al. Neurology. 2002 Mar 12;58(5):824-6. doi: 10.1212/wnl.58.5.824. Neurology. 2002. PMID: 11889253

9

Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS.

Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC. Villar LM, et al. Neurology. 2002 Aug 27;59(4):555-9. doi: 10.1212/wnl.59.4.555. Neurology. 2002. PMID: 12196648 Clinical Trial.

10

Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.

Villar LM, Masjuan J, González-Porqué P, Plaza J, Sádaba MC, Roldán E, Bootello A, Alvarez-Cermeño JC. Villar LM, et al. Ann Neurol. 2003 Feb;53(2):222-6. doi: 10.1002/ana.10441. Ann Neurol. 2003. PMID: 12557289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters